Literature DB >> 9201267

Desensitization of the fMLP-induced NADPH-oxidase response in human neutrophils is lacking in okadaic acid-treated cells.

O Harbecke1, L Liu, A Karlsson, C Dahlgren.   

Abstract

The chemoattractant N-formyl-methionyl-leucyl-phenylalanine (fMLP) interacts with neutrophils, generating signals that induce activation of the superoxide anion/hydrogen peroxide-producing NADPH-oxidase. Low temperature binding of fMLP to its neutrophil surface receptors is associated with a desensitization of the cells with respect to activation of the oxidase. Other stimuli can still activate the oxidase (in fact even induce a primed response), indicating that the observed phenomenon is stimulus specific and could not be accounted for by an effect on the oxidase itself. Furthermore, no desensitization is obtained in the presence of cytochalasin B, suggesting that the cytoskeleton is involved in the process leading to desensitization. Okadaic acid is a toxin produced by dinoflagellates and exerts its effects by an inhibition of cellular phosphatases. To investigate the role of phosphorylation/dephosphorylation events in the desensitization process we used okadaic acid as a scientific tool. We show that neutrophils treated with okadaic acid are primed with respect to the fMLP-induced production of superoxide anion, and that no desensitization is obtained in toxin-treated cells. Because the recovery of ligand-receptor complexes in a Triton X-100-insoluble fraction is very low in the cells treated with okadaic acid, we suggest that protein dephosphorylation is required to obtain binding to the cytoskeleton of occupied fMLP receptors; binding of the occupied receptors to the cell cytoskeleton being the mechanism behind desensitization.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9201267     DOI: 10.1002/jlb.61.6.753

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  7 in total

1.  Human neutrophil formyl peptide receptor phosphorylation and the mucosal inflammatory response.

Authors:  Giovanna Leoni; Jeannie Gripentrog; Connie Lord; Marcia Riesselman; Ronen Sumagin; Charles A Parkos; Asma Nusrat; Algirdas J Jesaitis
Journal:  J Leukoc Biol       Date:  2014-11-13       Impact factor: 4.962

Review 2.  Neutrophil Signaling That Challenges Dogmata of G Protein-Coupled Receptor Regulated Functions.

Authors:  Claes Dahlgren; André Holdfeldt; Simon Lind; Jonas Mårtensson; Michael Gabl; Lena Björkman; Martina Sundqvist; Huamei Forsman
Journal:  ACS Pharmacol Transl Sci       Date:  2020-03-11

3.  Role of nucleotides and phosphoinositides in the stability of electron and proton currents associated with the phagocytic NADPH oxidase.

Authors:  Gábor L Petheo; Nathalie C Girardin; Nicolas Goossens; Gergely Z Molnár; Nicolas Demaurex
Journal:  Biochem J       Date:  2006-12-15       Impact factor: 3.857

4.  Identification of C-terminal phosphorylation sites of N-formyl peptide receptor-1 (FPR1) in human blood neutrophils.

Authors:  Walid S Maaty; Connie I Lord; Jeannie M Gripentrog; Marcia Riesselman; Gal Keren-Aviram; Ting Liu; Edward A Dratz; Brian Bothner; Algirdas J Jesaitis
Journal:  J Biol Chem       Date:  2013-07-19       Impact factor: 5.157

5.  Reactivation of desensitized formyl peptide receptors by platelet activating factor: a novel receptor cross talk mechanism regulating neutrophil superoxide anion production.

Authors:  Huamei Forsman; Karin Önnheim; Emil Andréasson; Karin Christenson; Anna Karlsson; Johan Bylund; Claes Dahlgren
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

6.  The subcellular localization of the receptor for platelet-activating factor in neutrophils affects signaling and activation characteristics.

Authors:  Emil Andréasson; Karin Önnheim; Huamei Forsman
Journal:  Clin Dev Immunol       Date:  2013-08-29

7.  Gram-Negative Bacteria Salmonella typhimurium Boost Leukotriene Synthesis Induced by Chemoattractant fMLP to Stimulate Neutrophil Swarming.

Authors:  Ekaterina A Golenkina; Svetlana I Galkina; Olga Pletjushkina; Boris Chernyak; Tatjana V Gaponova; Yulia M Romanova; Galina F Sud'ina
Journal:  Front Pharmacol       Date:  2022-01-04       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.